January 06, 2014
Moderna Therapeutics to Present at 32nd Annual J.P. Morgan Healthcare Conference
December 17, 2013
Moderna Therapeutics Appoints Theo Melas-Kyriazi to Board of Directors
November 20, 2013
Moderna Closes New Financing Round Raising $110M to Develop Messenger RNA Therapeutics™
October 24, 2013
Moderna Therapeutics Named to the World Economic Forum’s Community of “Global Growth Companies”
October 17, 2013
Moderna Therapeutics Announces Expansion to New Headquarters and Laboratories at 200 Tech Square
October 02, 2013
DARPA Awards Moderna Therapeutics a Grant for up to $25 Million to Develop Messenger RNA Therapeutics™
September 24, 2013
Moderna Therapeutics Named a “Fierce 15” Biotech Company for 2013
September 08, 2013
Study Published in Nature Biotechnology Demonstrates Ability of Moderna’s Novel Therapeutic Paradigm to Repair and Regenerate Damaged Heart Tissue
July 31, 2013
Biotech Industry Veteran Joseph Bolen Joins Moderna Therapeutics to be President of Research and Development
May 22, 2013
Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer

Pages